The third transformative open access contract of the DEAL consortium has now been concluded with Elsevier. The University of Cologne is joining the contract with retroactive effect from 1 September 2023.

Reading at Elsevier:

For researchers and students at the University of Cologne and scientists at the University Hospital Cologne, this means that reading access to almost the entire journal portfolio, including Cell Press and the Lancet range of titles, is possible from the university network or VPN.

Publishing with Elsevier:

The University of Cologne participates in the DEAL contract with Elsevier and the two brands Cell Press and The Lancet. The contract covers approx. 1,800 subscription journals and 700 pure Open Access journals. To the current list of journals >>

Publications in subscription journals (hybrid journals)

Authors from the University of Cologne/University Hospital Cologne with the status "submitting corresponding author" have been able to publish Open Access in more than 2,500 Elsevier journals ("Core Hybrid"), including the journals of the Cell Press and The Lancet brands ("CP/TL Hybrid") since 1 September 2023.

In 2024, the costs for an open access publication "Core Hybrid" amount to € 2,500.00 net and for "Cell Press" and "The Lancet" € 6,450.00 net.

The costs of publications by scientists from the Faculty of Medicine are invoiced to the Faculty of Medicine/University Hospital. The Faculty of Medicine contributes to the costs.
The publication costs of the other faculties are supported by a central subsidy of € 700.00 gross per article. This subsidy is financed by the University and City Library of Cologne. The remaining costs are charged to the respective faculties. Please contact us to find out how much your faculty is contributing to the publication costs.

Publications in pure Open Access journals (gold journals = fully Open Access)

Authors from the University of Cologne/University Hospital Cologne receive a 20% discount on the list prices of publication fees (= Article Processing Charges, APCs) of the Elsevier Fully Gold Open Access journals ("Core Gold") and a 15% discount on the list prices of the Fully Gold Cell Press ("Cell Press Gold") and The Lancet journals ("The Lancet Gold"). The DFG grant can be applied for the Fully Gold Open Access article. The articles will be pre-financed by MPDL Services gGmbH (a subsidiary of the Max Planck Society for the Advancement of Science) during the course of the year and then invoiced periodically. Financing is provided by your chair or the faculty. The University and City Library of Cologne is responsible for all invoice processing and invoicing.

Licence selection

We recommend the licence "CC BY 4.0" for the licence selection ("Select your user licence").

Special rules for 2023

All authorised publications since 1 September 2023 will be identified retroactively by Elsevier, verified by the institution and can be converted to Open Access retrospectively. The authors will be contacted individually.
No service fee will be necessary for the articles in 2023, from 2024 a service fee of €100.00 net will be due for all articles in the DEAL-Elsevier contract.

Further links:

• DEAL Konsortium
• DFG grant of the University and City Library of Cologne
• Reading at Elsevier: Electronic full-text access via the publisher's website

Please note:

Please do not decide against the Open Access option.